Skip to main content
. 2021 Nov 26;22:71–78. doi: 10.1016/j.jmsacl.2021.11.004

Fig. 6.

Fig. 6

A) Bar plot showing the absolute intensity of Ga2[(d18:1)(C16:0)] biomarker and ceramide[(d18:1)(C16:0)] in the patient and control samples. B) Bar plot showing the Ga2[(d18:1)(C16:0)]/Ceramide[(d18:1)(C16:0)] peak area ratio in the patient and control samples.